We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Nano-Thin Superbug-Slaying Material Integrated into Implants Can Prevent or Heal Bacterial Infections

By HospiMedica International staff writers
Posted on 15 Sep 2023

Antibiotic resistance is turning into a severe worldwide health crisis, contributing to approximately 700,000 deaths each year. More...

This number could skyrocket to 10 million annual deaths by 2050 if new antibacterial treatments aren't developed. Superbugs, the culprits behind the huge health burdens, are bacteria that have grown resistant to antibiotics. As their resistance increases, it's becoming exceedingly difficult to manage and treat infections caused by these pathogens. Medical professionals globally are urgently seeking alternative ways to treat bacterial infections without relying on antibiotics. Now, researchers have invented a nano-thin superbug-eliminating material that can be used in wound dressings and implants to either prevent or treat bacterial infections.

Black phosphorus is the most stable form of phosphorus, a naturally occurring mineral found in numerous foods. In its ultra-thin form, black phosphorus easily degrades upon contact with oxygen, making it a potent microbe killer. A previous study led by researchers at RMIT University (Melbourne, VC, Australia) had found that when black phosphorus was used in nano-thin coatings on materials like cotton and titanium—common in wound dressings and implants—it effectively killed microbes. Their latest study examined how well this black phosphorus-based nanotechnology could perform in advanced infection treatments and wound healing.

The study found the treatment to be extremely effective, killing more than 99% of bacteria while sparing other cells in biological models. It achieved results comparable to antibiotics in wiping out infections and even promoted quicker wound healing, with wounds showing 80% closure within a week. The superbug-killing nanotechnology by RMIT exhibited rapid antimicrobial action and then self-decomposed after the infection risk was eliminated. It proved effective against a wide spectrum of antibiotic-resistant bacteria, including strains like 'golden staph,' commonly classified as superbugs. RMIT has moved to patent this innovative use of black phosphorus flakes, particularly its applications in wound healing products like gels.

“This is exciting as the treatment was comparable to the ciprofloxacin antibiotic in eradicating wound infection and resulted in accelerated healing, with wounds closing by 80% over seven days,” said lead researcher, Dr. Zlatko Kopecki. “We urgently need to develop new alternative non-antibiotic approaches to treat and manage wound infection. Black phosphorus seems to have hit the spot and we look forward to seeing the translation of this research towards clinical treatment of chronic wounds.”

Related Links:
RMIT University 


Gold Member
12-Channel ECG
CM1200B
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Rapid Sepsis Test
SeptiCyte RAPID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The study is the first to demonstrate a single nanomaterial platform that combines rapid blood clotting, activation of the body’s own latent growth factors, recruitment of bone-forming stem cells and enhanced bone regeneration. (Image Credit: Stef Zingsheim/University of Sydney)

Nanobone Material Activates Natural Repair Signals to Regrow Bone

Cleft lip and palate is a birth defect that affects about 1 in 700 children and occurs when parts of the upper lip or roof of the mouth do not fully fuse during pregnancy. Repairing the resulting jawbone... Read more

Medical Imaging

view channel
Images from patient T1, who had menstrual cycle–dependent right shoulder pain. (A) Maximum-intensity-projection images show abnormal findings for right diaphragm (arrowhead), bilateral round ligaments, peritoneum around bilateral ovaries, and left fallopian tube. Combined PET/MRI show hyperintense lesion with focal uptake inferior of right diaphragm, indicative of endometriosis (arrowhead, B). Confirmatory laparoscopy demonstrated extensive pelvic disease and implants of right diaphragm (C) that stained intensely positive for FAP (D).  (Image Credit: Schindler P, Brandt J, Bobe S, et al. Initial results of FAPI PET/MRI to assess the extent of endometriosis. J Nucl Med. 2026;67(8):1232–1238. doi:10.2967/jnumed.125.271376)

Targeted PET/MRI Improves Detection and Preoperative Mapping of Endometriosis

Endometriosis is a chronic inflammatory condition in which endometrial-like tissue grows outside the uterus, causing pelvic pain, infertility, and reduced quality of life. Conventional imaging can underestimate... Read more

Business

view channel
Image: Sempresto’s Smartphone-Integrated Epinephrine Auto-Injector Wins Red Dot Design Award (Photo courtesy of Sempresto)

Smartphone-Integrated Epinephrine Auto-Injector Concept Wins Red Dot Design Award

Severe allergic reactions can escalate rapidly and require prompt epinephrine, yet many at-risk patients do not consistently carry their auto-injector. With food allergies affecting an estimated 220 million... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.